Corporate Profile

CellSeed is a biotechnology innovator focused on novel surface and cell culture products. CellSeed is dedicated to providing innovative solutions for tissue-engineering through development of novel cell harvest methods and 3-dimensional living tissue replacement products for "Cell-sheet therapy" and regenerative medicine.
We are committed to providing solutions for patients suffering from certain incurable diseases. Our products seek to increase and improve human quality of life through technology innovations in cell culture and manipulation to achieve replacement tissue constructs.

Company Name	CellSeed Inc.
Main Business	Cell-sheet regenerative medicine Laboratory consumables and equipments
Head office	R-Bldg, Shinjuku 1F, 33-8, Wakamatsu-cho, Shinjuku-ku, Tokyo, 162-0056, Japan (  )
Branch office	1-21-7, Tomioka, Koto-ku, Tokyo, 135-0047, Japan
Date Established	2001. May
Management team	CEO Yukio Hasegawa, Ph.D Director Yasushi Hosono Director Kenichi Fukuhara Director Teruo Okano, Ph.D Director Hiromichi Kimura, Ph.D Director Tadakazu Shimizu Auditor Ichiro Kobayashi Auditor Noriko Sawai Auditor Toshio Yamaguchi
Accounting period	December
Listed market	JASDAQ Growth (7776)

Company profile of consolidated subsidiary

Company Name	CellSeed Europe Ltd.
Main Business	Research and development, marketing, and sales of Cell-sheet regenerative medicine in Europe
Head office	Crown House 72 Hammersmith Rd Hammersmith London W14 8TH , United Kingdom
Date Established	2010. Jun.
Our investment ratio	100％
CEO	Yukio Hasegawa, Ph.D
Accounting period	December

Company Name	CellSeed France SARL
Main Business	Research and development of Cell-sheet regenerative medicine in Europe
Head office	5 Place Charles Béraudier, 69428 Lyon, France
Date Established	2008. Oct.
Our investment ratio	100％
CEO	Yukio Hasegawa, Ph.D
Accounting period	December